tirzepatide press release Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease SURPASS-CVOT Published: Large Trial Confirms

Related Reading Ozempic For Weight Loss 2 Average Weight Loss On Ozempic Glp 1 For Weight Loss 2 Glp 1 Weight Loss Before And After Pricing and availability current as of June 2026

They need a BMI over 28 or 29, if they have other comorbidities and there's like a bunch of, like, they have to have heart issues, specific heart issues, some other things

Compounding Pharmacy Standards: What You Should Know SkinnyRx partners with state-licensed 503A compounding pharmacies that must meet both FDA regulations and state board of pharmacy requirements

Wellvita Glutathione & Collagen features thisblend of two key nutrients that assists with hair, skin and nails by nourishing your body from the inside out